Aifang Jiang

515 total citations
29 papers, 323 citations indexed

About

Aifang Jiang is a scholar working on Reproductive Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Aifang Jiang has authored 29 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Reproductive Medicine, 9 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Aifang Jiang's work include Endometriosis Research and Treatment (9 papers), Reproductive System and Pregnancy (7 papers) and Uterine Myomas and Treatments (4 papers). Aifang Jiang is often cited by papers focused on Endometriosis Research and Treatment (9 papers), Reproductive System and Pregnancy (7 papers) and Uterine Myomas and Treatments (4 papers). Aifang Jiang collaborates with scholars based in China. Aifang Jiang's co-authors include Chune Ren, Zhenhai Yu, Pengyun Qiao, Tingting Yang, Yuhan Meng, Mengxue Wang, Qiuyan Zhao, Qinghui Li, Yaoyao Fu and Junyi Jiang and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Aifang Jiang

27 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aifang Jiang China 11 116 113 102 89 60 29 323
Herta Bettendorf Germany 12 84 0.7× 65 0.6× 217 2.1× 55 0.6× 68 1.1× 15 387
Pi‐Lin Sung Taiwan 12 31 0.3× 109 1.0× 113 1.1× 108 1.2× 56 0.9× 16 340
Azam Zariff United States 3 229 2.0× 186 1.6× 315 3.1× 149 1.7× 342 5.7× 3 625
Yunwei Ouyang China 8 70 0.6× 63 0.6× 98 1.0× 79 0.9× 76 1.3× 24 282
Staffan R.B. Nordqvist United States 12 43 0.4× 95 0.8× 67 0.7× 111 1.2× 25 0.4× 26 349
John F. Langenheim United States 11 82 0.7× 91 0.8× 157 1.5× 67 0.8× 93 1.6× 21 414
Q.F. Kong United States 10 262 2.3× 200 1.8× 107 1.0× 98 1.1× 19 0.3× 11 398
Katarzyna Rainczuk Australia 11 143 1.2× 117 1.0× 84 0.8× 111 1.2× 46 0.8× 14 297
I. Pettersen Norway 8 79 0.7× 173 1.5× 55 0.5× 195 2.2× 35 0.6× 9 325
Shilong Fu China 12 56 0.5× 50 0.4× 207 2.0× 60 0.7× 217 3.6× 20 350

Countries citing papers authored by Aifang Jiang

Since Specialization
Citations

This map shows the geographic impact of Aifang Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aifang Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aifang Jiang more than expected).

Fields of papers citing papers by Aifang Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aifang Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aifang Jiang. The network helps show where Aifang Jiang may publish in the future.

Co-authorship network of co-authors of Aifang Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Aifang Jiang. A scholar is included among the top collaborators of Aifang Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aifang Jiang. Aifang Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ling, Dandan, et al.. (2025). Harnessing Nur77's mitochondrial apoptotic pathway: A promising therapeutic strategy for targeted disease intervention. Biomedicine & Pharmacotherapy. 187. 118091–118091.
2.
Yang, Weijing, Yan Wang, Yong Fu, et al.. (2025). Correlation between Castelli risk index-I and female infertility: A cross-sectional study. Lipids in Health and Disease. 24(1). 200–200. 1 indexed citations
3.
Wang, Mengxue, Shucai Zhang, Xiaohui Zhang, et al.. (2024). NEK2 promotes the development of ovarian endometriosis and impairs decidualization by phosphorylating FOXO1. Cellular and Molecular Life Sciences. 81(1). 237–237. 7 indexed citations
4.
Han, Xue, et al.. (2024). Arginine methylation of ALKBH5 by PRMT6 promotes breast tumorigenesis via LDHA-mediated glycolysis. Frontiers of Medicine. 18(2). 344–356. 9 indexed citations
5.
Wang, Zheng, et al.. (2024). CADM2 participates in endometriosis development by influencing the epithelial-mesenchymal transition. Reproductive Sciences. 31(10). 3049–3057.
6.
Han, Xue, Chao Lu, Aifang Jiang, et al.. (2024). Phosphorylation of USP27X by PIM2 promotes glycolysis and breast cancer progression via deubiquitylation of MYC. Oncogene. 43(33). 2493–2503. 3 indexed citations
7.
Wang, Mengxue, Ruiqi Fan, Junyi Jiang, et al.. (2023). PIM2 Promotes the Development of Ovarian Endometriosis by Enhancing Glycolysis and Fibrosis. Reproductive Sciences. 30(9). 2692–2702. 12 indexed citations
8.
Liu, Lan, Aifang Jiang, Xiaodan Shi, et al.. (2023). PFKFB3 promotes endometriosis cell proliferation via enhancing the protein stability of β-catenin. Molecular and Cellular Endocrinology. 579. 112083–112083. 2 indexed citations
9.
Zhang, Yanan, Zeyang Chen, Aifang Jiang, & Guan-Qi Gao. (2022). KLRK1 as a prognostic biomarker for lung adenocarcinoma cancer. Scientific Reports. 12(1). 1976–1976. 10 indexed citations
10.
Fan, Ruiqi, Aifang Jiang, Junyi Jiang, et al.. (2022). The effect of flexible low-dose GnRH antagonist on pregnancy outcome in the fresh embryo transfer cycle of IVF-ET: a randomized controlled trial. Reproductive Biology and Endocrinology. 20(1). 55–55. 3 indexed citations
11.
Fan, Ruiqi, et al.. (2022). New Insights on Ferroptosis and Gynecological Malignancies. Frontiers in Molecular Biosciences. 9. 921298–921298. 2 indexed citations
12.
Liu, Lu, et al.. (2022). Emerging hallmarks of endometriosis metabolism: A promising target for the treatment of endometriosis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1870(1). 119381–119381. 24 indexed citations
13.
Wang, Qian, et al.. (2022). Role of inflammatory factors in the etiology and treatment of recurrent implantation failure. Reproductive Biology. 22(4). 100698–100698. 19 indexed citations
14.
Zhao, Qiuyan, Qinghui Li, Yaoyao Fu, et al.. (2022). Decidual macrophages in recurrent spontaneous abortion. Frontiers in Immunology. 13. 994888–994888. 38 indexed citations
15.
Wang, Mengxue, Pengyun Qiao, Aifang Jiang, et al.. (2022). CHIP induces ubiquitination and degradation of HMGB1 to regulate glycolysis in ovarian endometriosis. Cellular and Molecular Life Sciences. 80(1). 13–13. 19 indexed citations
16.
17.
Han, Xue, Chune Ren, Tingting Yang, et al.. (2019). Negative regulation of AMPKα1 by PIM2 promotes aerobic glycolysis and tumorigenesis in endometrial cancer. Oncogene. 38(38). 6537–6549. 33 indexed citations
18.
Yang, Tingting, Chune Ren, Aifang Jiang, et al.. (2017). RIZ1 is regulated by estrogen and suppresses tumor progression in endometrial cancer. Biochemical and Biophysical Research Communications. 489(2). 96–102. 10 indexed citations
19.
Yu, Zhenhai, Liangqian Huang, Pengyun Qiao, et al.. (2016). PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells. Biochemical and Biophysical Research Communications. 473(4). 953–958. 31 indexed citations
20.
Cheng, Ruhong, Ming Li, Hui Zhang, et al.. (2012). Common FLG Mutation K4671X Not Associated with Atopic Dermatitis in Han Chinese in a Family Association Study. PLoS ONE. 7(11). e49158–e49158. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herta Bettendorf Breakdown of academic impact, for papers by Pi‐Lin Sung Breakdown of academic impact, for papers by Azam Zariff Breakdown of academic impact, for papers by Yunwei Ouyang Breakdown of academic impact, for papers by Staffan R.B. Nordqvist Breakdown of academic impact, for papers by John F. Langenheim Breakdown of academic impact, for papers by Q.F. Kong Breakdown of academic impact, for papers by Katarzyna Rainczuk Breakdown of academic impact, for papers by I. Pettersen Breakdown of academic impact, for papers by Shilong Fu
Rankless by CCL
2026